Compare $ESLA vs $VICP | Chartloom

Compare

$ESLA vs $VICP

Estrella Immunopharma Inc · Vicapsys Life Sciences Inc

ESLA

Estrella Immunopharma Inc

VICP

Vicapsys Life Sciences Inc

Compare $ESLA vs $VICP

Comparing Estrella Immunopharma Inc and Vicapsys Life Sciences Inc

ESLAEstrella Immunopharma Inc

VICPVicapsys Life Sciences Inc

ESLAEstrella Immunopharma Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.5%

52W performance

-68.5%

FCF yield

-53.2%

VICPVicapsys Life Sciences Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.3%

52W performance

-68.9%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ESLA

VICP

Detailed metrics comparison

ESLA

Estrella Immunopharma Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

ESLA$18M

VICP$18M

Enterprise Value

ESLA$17M

VICP$18M

Price

ESLA$0.41

VICP$0.55

P/E Ratio

ESLAN/A

VICPN/A

P/S Ratio

ESLA0.00x

VICP0.00x

EV/Sales

ESLA0.00x

VICP0.00x

EV/EBITDA

ESLA0.00x

VICP0.00x

P/B Ratio

ESLA141.63x

VICPN/A

P/FCF Ratio

ESLAN/A

VICPN/A

EV/FCF

ESLA-1.86x

VICP0.00x

PEG Ratio

ESLAN/A

VICPN/A

Forward P/E (NTM)

ESLAN/A

VICPN/A

Forward P/S (NTM)

ESLAN/A

VICPN/A

Revenue (TTM)

ESLA$0

VICP$0

Revenue Growth (YoY)

ESLAN/A

VICPN/A

Forward Rev Growth

ESLA0.0%

VICP0.0%

Gross Margin (TTM)

ESLA0.0%

VICP0.0%

Operating Margin (TTM)

ESLA0.0%

VICP0.0%

EBITDA Margin (TTM)

ESLA0.0%

VICP0.0%

Net Margin (TTM)

ESLA0.0%

VICP0.0%

FCF Margin (TTM)

ESLAN/A

VICPN/A

Net Income (TTM)

ESLA$-10M

VICPN/A

FCF (TTM)

ESLA$-9M

VICP$0

EPS (TTM)

ESLA-$0.23

VICP$0.00

ROE (TTM)

ESLA-25911.0%

VICP0.0%

ROA (TTM)

ESLA-32876.0%

VICP0.0%

ROIC (TTM)

ESLA-25911.0%

VICP0.0%

Cash

ESLA$147K

VICP$90K

Debt

ESLA$0

VICP$579K

Net Cash/Debt

ESLA$147K

VICP$-489K

Current Ratio (TTM)

ESLA0.20x

VICP0.03x

Quick Ratio (TTM)

ESLA0.02x

VICP0.03x

Debt/Equity (TTM)

ESLA0.00x

VICP0.00x

Debt/Assets (TTM)

ESLA0.0%

VICP0.0%

Interest Coverage (TTM)

ESLAN/A

VICPN/A

Net Debt/EBITDA (TTM)

ESLA0.00x

VICP0.00x

Beta

ESLA0.98

VICP-3.98

52W Performance

ESLA-68.5%

VICP-68.9%

YTD Performance

ESLA-70.5%

VICP-63.3%

% from 52W High

ESLA-87.0%

VICP-68.9%

% from 52W Low

ESLA33.0%

VICP399.9%

Asset Turnover (TTM)

ESLA0.00x

VICP0.00x

FCF Yield (TTM)

ESLA-53.2%

VICP0.0%

Earnings Yield (TTM)

ESLA-56.8%

VICP0.0%

Dividend Yield (TTM)

ESLAN/A

VICPN/A

Rule of 40

ESLA0.0

VICP0.0

EV/GP/RG

ESLAN/A

VICPN/A

Ticker research

View ESLA research View VICP research

Metric	ESLA Estrella Immunopharma Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$18M	$18M
Enterprise Value	$17M	$18M
Price	$0.41	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	141.63x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-1.86x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	N/A
FCF (TTM)	$-9M	$0
EPS (TTM)	-$0.23	$0.00
ROE (TTM)	-25911.0%	0.0%
ROA (TTM)	-32876.0%	0.0%
ROIC (TTM)	-25911.0%	0.0%
Financial Health
Cash	$147K	$90K
Debt	$0	$579K
Net Cash/Debt	$147K	$-489K
Current Ratio (TTM)	0.20x	0.03x
Quick Ratio (TTM)	0.02x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	-3.98
52W Performance	-68.5%	-68.9%
YTD Performance	-70.5%	-63.3%
% from 52W High	-87.0%	-68.9%
% from 52W Low	33.0%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-53.2%	0.0%
Earnings Yield (TTM)	-56.8%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ESLA research	View VICP research

Valuation

P/S Ratio

ESLA

0.00x

VICP

0.00x

EV/FCF

ESLA

-1.86x

VICP

0.00x

Growth & revenue

Forward Revenue Growth

ESLA

0.0%

VICP

0.0%

Profitability & performance

Gross Margin

ESLA

0.0%

VICP

0.0%

ROE

VICP

0.0%

ESLA

-25911.0%

FCF Yield %

VICP

0.0%

ESLA

-53.2%

52-Week Performance

ESLA

-68.5%

VICP

-68.9%

Detailed metrics comparison

ESLA

Estrella Immunopharma Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

ESLA$18M

VICP$18M

Enterprise Value

ESLA$17M

VICP$18M

Price

ESLA$0.41

VICP$0.55

P/E Ratio

ESLAN/A

VICPN/A

P/S Ratio

ESLA0.00x

VICP0.00x

EV/Sales

ESLA0.00x

VICP0.00x

EV/EBITDA

ESLA0.00x

VICP0.00x

P/B Ratio

ESLA141.63x

VICPN/A

P/FCF Ratio

ESLAN/A

VICPN/A

EV/FCF

ESLA-1.86x

VICP0.00x

PEG Ratio

ESLAN/A

VICPN/A

Forward P/E (NTM)

ESLAN/A

VICPN/A

Forward P/S (NTM)

ESLAN/A

VICPN/A

Revenue (TTM)

ESLA$0

VICP$0

Revenue Growth (YoY)

ESLAN/A

VICPN/A

Forward Rev Growth

ESLA0.0%

VICP0.0%

Gross Margin (TTM)

ESLA0.0%

VICP0.0%

Operating Margin (TTM)

ESLA0.0%

VICP0.0%

EBITDA Margin (TTM)

ESLA0.0%

VICP0.0%

Net Margin (TTM)

ESLA0.0%

VICP0.0%

FCF Margin (TTM)

ESLAN/A

VICPN/A

Net Income (TTM)

ESLA$-10M

VICPN/A

FCF (TTM)

ESLA$-9M

VICP$0

EPS (TTM)

ESLA-$0.23

VICP$0.00

ROE (TTM)

ESLA-25911.0%

VICP0.0%

ROA (TTM)

ESLA-32876.0%

VICP0.0%

ROIC (TTM)

ESLA-25911.0%

VICP0.0%

Cash

ESLA$147K

VICP$90K

Debt

ESLA$0

VICP$579K

Net Cash/Debt

ESLA$147K

VICP$-489K

Current Ratio (TTM)

ESLA0.20x

VICP0.03x

Quick Ratio (TTM)

ESLA0.02x

VICP0.03x

Debt/Equity (TTM)

ESLA0.00x

VICP0.00x

Debt/Assets (TTM)

ESLA0.0%

VICP0.0%

Interest Coverage (TTM)

ESLAN/A

VICPN/A

Net Debt/EBITDA (TTM)

ESLA0.00x

VICP0.00x

Beta

ESLA0.98

VICP-3.98

52W Performance

ESLA-68.5%

VICP-68.9%

YTD Performance

ESLA-70.5%

VICP-63.3%

% from 52W High

ESLA-87.0%

VICP-68.9%

% from 52W Low

ESLA33.0%

VICP399.9%

Asset Turnover (TTM)

ESLA0.00x

VICP0.00x

FCF Yield (TTM)

ESLA-53.2%

VICP0.0%

Earnings Yield (TTM)

ESLA-56.8%

VICP0.0%

Dividend Yield (TTM)

ESLAN/A

VICPN/A

Rule of 40

ESLA0.0

VICP0.0

EV/GP/RG

ESLAN/A

VICPN/A

Ticker research

View ESLA research View VICP research

Metric	ESLA Estrella Immunopharma Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$18M	$18M
Enterprise Value	$17M	$18M
Price	$0.41	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	141.63x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-1.86x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	N/A
FCF (TTM)	$-9M	$0
EPS (TTM)	-$0.23	$0.00
ROE (TTM)	-25911.0%	0.0%
ROA (TTM)	-32876.0%	0.0%
ROIC (TTM)	-25911.0%	0.0%
Financial Health
Cash	$147K	$90K
Debt	$0	$579K
Net Cash/Debt	$147K	$-489K
Current Ratio (TTM)	0.20x	0.03x
Quick Ratio (TTM)	0.02x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	-3.98
52W Performance	-68.5%	-68.9%
YTD Performance	-70.5%	-63.3%
% from 52W High	-87.0%	-68.9%
% from 52W Low	33.0%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-53.2%	0.0%
Earnings Yield (TTM)	-56.8%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ESLA research	View VICP research